Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

130th anniversary of Institut Pasteur: celebrating science.

Gougeon ML, Schwartz M, Brunner T, Ojcius DM.

Genes Immun. 2019 May;20(5):342-343. doi: 10.1038/s41435-019-0070-3. Epub 2019 Apr 25. No abstract available.

PMID:
31019251
2.

Message from the new Editors-in-Chief.

Brunner T, Gougeon ML.

Genes Immun. 2019 Apr;20(4):338-339. doi: 10.1038/s41435-018-0043-y. Epub 2018 Aug 17. No abstract available.

PMID:
30115974
3.

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death.

Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, Brenner C, Ojcius DM, Kroemer G, Modjtahedi N, Deutsch E, Perfettini JL.

Cell Death Dis. 2018 Jun 18;9(7):716. doi: 10.1038/s41419-018-0747-y.

4.

Targeted Magnetic Intra-Lysosomal Hyperthermia produces lysosomal reactive oxygen species and causes Caspase-1 dependent cell death.

Clerc P, Jeanjean P, Hallali N, Gougeon M, Pipy B, Carrey J, Fourmy D, Gigoux V.

J Control Release. 2018 Jan 28;270:120-134. doi: 10.1016/j.jconrel.2017.11.050. Epub 2017 Dec 1.

PMID:
29203413
5.

CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.

Goujon C, Gougeon ML, Tondeur L, Poirier B, Seffer V, Desprès P, Consigny PH, Vray M; study group.

Vaccine. 2017 Oct 27;35(45):6166-6171. doi: 10.1016/j.vaccine.2017.09.047. Epub 2017 Sep 25.

PMID:
28958813
6.

Bi2(C2O4)3·7H2O and Bi(C2O4)OH Oxalates Thermal Decomposition Revisited. Formation of Nanoparticles with a Lower Melting Point than Bulk Bismuth.

Roumanille P, Baco-Carles V, Bonningue C, Gougeon M, Duployer B, Monfraix P, Le Trong H, Tailhades P.

Inorg Chem. 2017 Aug 21;56(16):9486-9496. doi: 10.1021/acs.inorgchem.7b00608. Epub 2017 Aug 3.

PMID:
28771337
7.

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.

Tardieu M, Zérah M, Gougeon ML, Ausseil J, de Bournonville S, Husson B, Zafeiriou D, Parenti G, Bourget P, Poirier B, Furlan V, Artaud C, Baugnon T, Roujeau T, Crystal RG, Meyer C, Deiva K, Heard JM.

Lancet Neurol. 2017 Sep;16(9):712-720. doi: 10.1016/S1474-4422(17)30169-2. Epub 2017 Jul 14.

PMID:
28713035
8.

Nordic Walking improves trunk stability and gait spatial-temporal characteristics in people with Parkinson disease.

Gougeon MA, Zhou L, Nantel J.

NeuroRehabilitation. 2017;41(1):205-210. doi: 10.3233/NRE-171472.

PMID:
28527231
9.

Nordic Walking Improves Gait Power Profiles at the Knee Joint in Parkinson's Disease.

Zhou L, Gougeon MA, Nantel J.

J Aging Phys Act. 2018 Jan 1;26(1):84-88. doi: 10.1123/japa.2017-0031. Epub 2017 Dec 9.

PMID:
28459391
10.

Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'.

Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M.

Heliyon. 2017 Mar 16;3(3):e00259. doi: 10.1016/j.heliyon.2017.e00259. eCollection 2017 Mar.

11.

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).

Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M.

Heliyon. 2017 Feb 13;3(2):e00245. doi: 10.1016/j.heliyon.2017.e00245. eCollection 2017 Feb. Erratum in: Heliyon. 2017 Mar 16;3(3):e00259.

12.

Alarmins and central nervous system inflammation in HIV-associated neurological disorders.

Gougeon ML.

J Intern Med. 2017 May;281(5):433-447. doi: 10.1111/joim.12570. Epub 2016 Nov 16. Review.

13.

HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.

Saïdi H, Bras M, Formaglio P, Melki MT, Charbit B, Herbeuval JP, Gougeon ML.

PLoS Pathog. 2016 Feb 12;12(2):e1005407. doi: 10.1371/journal.ppat.1005407. eCollection 2016 Feb.

14.

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, Kepp O, Kroemer G, Krysko DV, Land WG, Madeo F, Manfredi AA, Mattarollo SR, Maueroder C, Merendino N, Multhoff G, Pabst T, Ricci JE, Riganti C, Romano E, Rufo N, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Vacchelli E, Vandenabeele P, Vandenberk L, Van den Eynde BJ, Van Gool S, Velotti F, Zitvogel L, Agostinis P.

Front Immunol. 2015 Nov 20;6:588. doi: 10.3389/fimmu.2015.00588. eCollection 2015.

15.

Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.

Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F; MICIVAX Study Group.

J Crohns Colitis. 2015 Dec;9(12):1096-107. doi: 10.1093/ecco-jcc/jjv152. Epub 2015 Sep 7.

PMID:
26351392
16.

Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.

Dudek-Perić AM, Ferreira GB, Muchowicz A, Wouters J, Prada N, Martin S, Kiviluoto S, Winiarska M, Boon L, Mathieu C, van den Oord J, Stas M, Gougeon ML, Golab J, Garg AD, Agostinis P.

Cancer Res. 2015 Apr 15;75(8):1603-14. doi: 10.1158/0008-5472.CAN-14-2089. Epub 2015 Mar 11.

17.

Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization.

Loison E, Gougeon ML.

Hum Vaccin Immunother. 2014;10(8):2328-35. doi: 10.4161/hv.29520.

18.

Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.

Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vély F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F.

J Epidemiol Community Health. 2015 Mar;69(3):272-7. doi: 10.1136/jech-2014-204678. Epub 2014 Nov 21.

19.

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Muñoz-Pinedo C, Nuñez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G.

Cell Death Differ. 2015 Jan;22(1):58-73. doi: 10.1038/cdd.2014.137. Epub 2014 Sep 19. Review.

20.

Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus.

Viguier M, Bachelez H, Poirier B, Kagan J, Battistella M, Aubin F, Touzé A, Carmagnat M, Francès C, Gougeon ML, Fazilleau N.

J Invest Dermatol. 2015 Feb;135(2):418-424. doi: 10.1038/jid.2014.397. Epub 2014 Sep 10.

21.

Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.

Lafeuillade A, Wainberg M, Gougeon ML, Loes SK, Halfon P, Tissot-Dupont H.

AIDS Res Ther. 2014 Aug 21;11:28. doi: 10.1186/1742-6405-11-28. eCollection 2014.

22.

Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cells.

Loison E, Poirier-Beaudouin B, Seffer V, Paoletti A, Abitbol V, Tartour E, Launay O, Gougeon ML.

PLoS One. 2014 Apr 1;9(4):e92705. doi: 10.1371/journal.pone.0092705. eCollection 2014.

23.

Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death.

Sanchez C, El Hajj Diab D, Connord V, Clerc P, Meunier E, Pipy B, Payré B, Tan RP, Gougeon M, Carrey J, Gigoux V, Fourmy D.

ACS Nano. 2014 Feb 25;8(2):1350-63. doi: 10.1021/nn404954s. Epub 2014 Jan 14.

PMID:
24401079
24.

MAIT cells detect and efficiently lyse bacterially-infected epithelial cells.

Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V, Coré M, Sleurs D, Serriari NE, Treiner E, Hivroz C, Sansonetti P, Gougeon ML, Soudais C, Lantz O.

PLoS Pathog. 2013;9(10):e1003681. doi: 10.1371/journal.ppat.1003681. Epub 2013 Oct 10.

25.

Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans.

Chauvat A, Benhamouda N, Gey A, Lemoine FM, Paulie S, Carrat F, Gougeon ML, Rozenberg F, Krivine A, Cherai M, Lehmann P 5th, Quintin-Colonna F, Launay O, Tartour E.

Hum Vaccin Immunother. 2014;10(1):104-13. doi: 10.4161/hv.26593. Epub 2013 Oct 1.

26.

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Prada N, Antoni G, Commo F, Rusakiewicz S, Semeraro M, Boufassa F, Lambotte O, Meyer L, Gougeon ML, Zitvogel L.

Oncoimmunology. 2013 Mar 1;2(3):e23472.

27.

Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.

Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F.

PLoS One. 2013 Apr 16;8(4):e60127. doi: 10.1371/journal.pone.0060127. Print 2013.

28.

[The vaccination of older adults: a challenge for the future!].

Bonnal C, Desaint C, Raynaud-Simon A, Fossey-Diaz V, Gougeon ML, Lucet JC, Launay O.

Presse Med. 2013 Mar;42(3):318-26. doi: 10.1016/j.lpm.2012.04.024. Epub 2012 Jun 28. French.

PMID:
22748858
29.

Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.

Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F.

BMC Public Health. 2012 Jun 7;12:417. doi: 10.1186/1471-2458-12-417.

30.

IFN-α and TRAIL: a double edge sword in HIV-1 disease?

Gougeon ML, Herbeuval JP.

Exp Cell Res. 2012 Jul 1;318(11):1260-8. doi: 10.1016/j.yexcr.2012.03.012. Epub 2012 Mar 26. Review.

PMID:
22480868
31.

Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.

Chauvat A, Benhamouda N, Loison E, Gougeon ML, Gey A, Levionnois E, Ravel P, Abitbol V, Roncelin S, Marcheteau E, Quintin-Colonna F, Fridman WH, Launay O, Tartour E.

J Immunol Methods. 2012 Apr 30;378(1-2):81-7. doi: 10.1016/j.jim.2012.02.008. Epub 2012 Feb 16.

PMID:
22366633
32.

Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selection.

Cole DK, Gallagher K, Lemercier B, Holland CJ, Junaid S, Hindley JP, Wynn KK, Gostick E, Sewell AK, Gallimore AM, Ladell K, Price DA, Gougeon ML, Godkin A.

Nat Commun. 2012 Feb 7;3:665. doi: 10.1038/ncomms1665.

33.

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.

Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G; ILIADE Study Group.

AIDS. 2012 Mar 27;26(6):711-20. doi: 10.1097/QAD.0b013e3283519214.

PMID:
22301410
34.

IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells.

Le Buanec H, Gougeon ML, Mathian A, Lebon P, Dupont JM, Peltre G, Hemon P, Schmid M, Bizzini B, Künding T, Burny A, Bensussan A, Amoura Z, Gallo RC, Zagury D.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18995-9000. doi: 10.1073/pnas.1113301108. Epub 2011 Nov 7.

35.

HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells.

Gougeon ML, Melki MT, Saïdi H.

Cell Death Differ. 2012 Jan;19(1):96-106. doi: 10.1038/cdd.2011.134. Epub 2011 Oct 28. Review.

36.

Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.

Séror C, Melki MT, Subra F, Raza SQ, Bras M, Saïdi H, Nardacci R, Voisin L, Paoletti A, Law F, Martins I, Amendola A, Abdul-Sater AA, Ciccosanti F, Delelis O, Niedergang F, Thierry S, Said-Sadier N, Lamaze C, Métivier D, Estaquier J, Fimia GM, Falasca L, Casetti R, Modjtahedi N, Kanellopoulos J, Mouscadet JF, Ojcius DM, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL.

J Exp Med. 2011 Aug 29;208(9):1823-34. doi: 10.1084/jem.20101805. Epub 2011 Aug 22.

37.

Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection?

Gougeon ML, Bras M.

Curr Opin HIV AIDS. 2011 Sep;6(5):364-72. doi: 10.1097/COH.0b013e328349b089. Review.

PMID:
21825870
38.

Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?

Agrati C, D'Offizi G, Gougeon ML, Malkovsky M, Sacchi A, Casetti R, Bordoni V, Cimini E, Martini F.

AIDS Rev. 2011 Jan-Mar;13(1):3-12. Review.

PMID:
21412385
39.

Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Rizzi M, Knoth R, Hampe CS, Lorenz P, Gougeon ML, Lemercier B, Venhoff N, Ferrera F, Salzer U, Thiesen HJ, Peter HH, Walker UA, Eibel H.

PLoS One. 2010 May 26;5(5):e10838. doi: 10.1371/journal.pone.0010838.

40.

The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

Carsenti-Dellamonica H, Saïdi H, Ticchioni M, Guillouet de Salvador F, Dufayard Cottalorda J, Garraffo R, Dellamonica P, Durant J, Gougeon ML.

HIV Med. 2011 Feb;12(2):65-77. doi: 10.1111/j.1468-1293.2010.00848.x.

41.

Impact of gamma-chain cytokines on T cell homeostasis in HIV-1 infection: therapeutic implications.

Gougeon ML, Chiodi F.

J Intern Med. 2010 May;267(5):502-14. doi: 10.1111/j.1365-2796.2010.02221.x. Review.

42.

Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.

Melki MT, Saïdi H, Dufour A, Olivo-Marin JC, Gougeon ML.

PLoS Pathog. 2010 Apr 15;6(4):e1000862. doi: 10.1371/journal.ppat.1000862.

43.

Evaluation of ash pollen sensitization pattern using proteomic approach with individual sera from allergic patients.

Poncet P, Senechal H, Clement G, Purohit A, Sutra JP, Desvaux FX, Wal JM, Pauli G, Peltre G, Gougeon ML.

Allergy. 2010 May;65(5):571-80. doi: 10.1111/j.1398-9995.2009.02231.x. Epub 2009 Nov 3.

PMID:
19886925
44.

53BP1 represses mitotic catastrophe in syncytia elicited by the HIV-1 envelope.

Perfettini JL, Nardacci R, Séror C, Raza SQ, Sepe S, Saïdi H, Brottes F, Amendola A, Subra F, Del Nonno F, Chessa L, D'Incecco A, Gougeon ML, Piacentini M, Kroemer G.

Cell Death Differ. 2010 May;17(5):811-20. doi: 10.1038/cdd.2009.159. Epub 2009 Oct 30.

45.

A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Legrand F, Driss V, Woerly G, Loiseau S, Hermann E, Fournié JJ, Héliot L, Mattot V, Soncin F, Gougeon ML, Dombrowicz D, Capron M.

PLoS One. 2009 Jun 17;4(6):e5926. doi: 10.1371/journal.pone.0005926.

46.

Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).

Molina JM, Levy Y, Fournier I, Hamonic S, Bentata M, Beck-Wirth G, Gougeon ML, Venet A, Madelaine I, Sereni D, Jeanblanc F, Boulet T, Simon F, Aboulker JP; Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 119 Interstart Study Team.

J Infect Dis. 2009 Jul 15;200(2):206-15. doi: 10.1086/599989.

PMID:
19508157
47.

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnóczky G, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G.

Cell Death Differ. 2009 Aug;16(8):1093-107. doi: 10.1038/cdd.2009.44. Epub 2009 Apr 17. Review.

48.

New insights on the role of apoptosis and autophagy in HIV pathogenesis.

Gougeon ML, Piacentini M.

Apoptosis. 2009 Apr;14(4):501-8. doi: 10.1007/s10495-009-0314-1. Review.

PMID:
19199038
49.

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.

Launay O, Sadorge C, Jolly N, Poirier B, Béchet S, van der Vliet D, Seffer V, Fenner N, Dowling K, Giemza R, Johnson J, Ndiaye A, Vray M, Sansonetti P, Morand P, Poyart C, Lewis D, Gougeon ML.

Vaccine. 2009 Feb 18;27(8):1184-91. doi: 10.1016/j.vaccine.2008.12.021. Epub 2009 Jan 9.

PMID:
19135496
50.

The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope.

Perfettini JL, Nardacci R, Séror C, Bourouba M, Subra F, Gros L, Manic G, Amendola A, Masdehors P, Rosselli F, Ojcius DM, Auclair C, de Thé H, Gougeon ML, Piacentini M, Kroemer G.

Cell Death Differ. 2009 Feb;16(2):298-311. doi: 10.1038/cdd.2008.158. Epub 2008 Nov 21.

Supplemental Content

Loading ...
Support Center